Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 150 Mcg (0.15 Mg), 1000-count Bottles
Recall Summary Accord Healthcare is recalling Levothyroxine Sodium Tablets (150 mcg) in 1,000-count bottles nationwide because the medication is subpotent—meaning it contains less active ingredient than it should. This thyroid medication was distributed across all U.S. states and the District of Columbia. The recall affects prescription bottles with NDC number 16729-455-17 manufactured by Intas Pharmaceuticals Limited in India.
- Recalling firm
- ACCORD HEALTHCARE, INC.
- Product
- Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17.
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/24a80bfe-579d-4f75-8755-bc87df55da81